Am J Respir Crit Care Med
- ALFFENAAR JC
Isoniazid for Preventive Treatment among Contacts of Multidrug-Resistant
Tuberculosis; Does It Make Sense?
Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202509-2319.
- YANG X, Tao S, Jin C
Advancing Tuberculosis Care through Evidence-based Short-Course Regimens.
Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202507-1750.
Clin Infect Dis
- LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
Maternal, pregnancy and infant outcomes in women treated for
multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in
KwaZulu-Natal, South Africa.
Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
- WIJK M, Denti P, Gausi K, Myers B, et al
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on
the Response to Pulmonary Tuberculosis Treatment.
Clin Infect Dis. 2025 Oct 24:ciaf586. doi: 10.1093.
Eur J Clin Microbiol Infect Dis
- KIM Y, Lee DG, Bae J, Jung J, et al
Characteristic exploration of Mycobacterium tuberculosis isolated from patients
with linezolid-treated multidrug-resistant tuberculosis.
Eur J Clin Microbiol Infect Dis. 2025 Oct 29. doi: 10.1007/s10096-025-05319.
J Clin Microbiol
- FOLKESSON E, Foroogh F, Kleberg L, Kjellgren V, et al
A multiplex Mtb-specific FluoroSpot assay measuring IFNgamma, IL-2, and TNF-secreting
cells can improve accuracy and differentiation across the tuberculosis spectrum.
J Clin Microbiol. 2025 Oct 29:e0089425. doi: 10.1128/jcm.00894.
J Infect Dis
- HUGHES JA, McMorrow F, Brooks KM, Pinilla M, et al
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant
Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT
P1026s.
J Infect Dis. 2025 Oct 30:jiaf504. doi: 10.1093.
PLoS One
- DAVID A, Peloakgosi-Shikwambani K, Nsingwane Z, Molepo V, et al
Challenges, innovations and considerations for the use of tongue swabs in
Mycobacterium tuberculosis complex detection.
PLoS One. 2025;20:e0325585.
- YANG S, Ren Y, Wu Y, Li X, et al
The impact of CwlM depletion on the susceptibility of Mycobacterium smegmatis to
anti-tuberculosis drugs.
PLoS One. 2025;20:e0334937.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016